RGNX

Regenxbio Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 0/10
Regenxbio sales and earnings growth
RGNX Growth
Good
  • Revenue Y/Y↑ 104.54%
  • EPS Y/Y↑ 18.08%
  • FCF Y/Y↑ 28.02%
Regenxbio gross and profit margin trends
RGNX Profitability
Neutral
  • Gross margin ↑ 88.10%
  • EPS margin↓ -113.80%
  • ROIC 5Y↓ -33.95%
Regenxbio net debt vs free cash flow
RGNX Risk
Fair
  • Debt / Equity↑ 2.5
  • Debt / FCF↓ 1.8
  • Interest coverage↓ -3.3

Regenxbio stock volatility is higher than the overall market. We give it a Fair risk rating.

↗ More Biotechnology stocks